Apigenin based nanoplatform achieves non-small cell lung cancer immunotherapy through glycolysis inhibition and photodynamic co-perturbation of organelles
{{output}}
Effective treatment of non-small cell lung cancer (NSCLC) remains challenging due to its immunosuppressive tumor microenvironment, metabolic adaptability, and resistance to conventional therapies. To improve the treatment efficiency of NSCLC, we developed a mu... ...
